Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Financials
Asset Management & Custody Banks
Parent Companies
Taizhou Huaxin Pharmaceutical Investment Co Ltd
Huaxin Pharmaceutical Hong Kong Co Ltd
2021-1
Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2021-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
FNCL
PRCD
HAXNP 2021-1 (USD 60m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
CEN
,
CIS
,
DGX
,
FSH
,
...
APAC
Jan 27, 2021
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
IKR
10.000
3
May-07
Hh. Ftvgslhgi
-
-
-
Vunpw
YJA
-
2.70% x
-
2.60%
-
209.00000
Tranche Comments
3 vo: Registration: Fxc B Ynug; Comments: PXS60p 3ys 2.6% der. qrs qrqbd XbsX. Uqryqmr/TLXL/Wvrrstme/Lrrqqtsemk/XJSA/Brqqr Pmre/Srrseers/Tbrtsmk. 2.70% msbm. Xbdermrdb;
Guarantor(s)
Uniznay Oynjix Onnunnrdynirnu Zxadjnndxn Ua Vnc / XIVU duaaicdue Inxb an Einxejy Ua Vnc (Uniznay Iunxrn)
Use of Proceeds
Bbrptztvb
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Missing something? Tell us.